Demand of North American Dietary Supplements increase as Personalized Subscriptions, Healthy Aging, and GLP-1 Adjacent Nutrition Reshape Buying Decisions
NEWARK, Del., March 5, 2026 /PRNewswire/ -- Future Market Insights (FMI) projects the North American dietary supplements market reached USD 79.2 billion in 2025 and is projected to grow to USD 85.1 billion in 2026 and USD 175.5 billion by 2036, expanding at a 7.5% CAGR over the forecast period. The decade's absolute dollar growth of USD 90.4 billion reflects a market moving beyond 'daily multivitamins' into condition-specific, clinically positioned, and digitally personalized regimens—with procurement and margin strategies increasingly shaped by raw material volatility and channel shifts.
Market Snapshot: North American Dietary Supplements Demands
Download North American Dietary Supplements Market Report Sample: https://www.futuremarketinsights.com/reports/brochure/rep-na-244
What's Changing: From Shelf Competition to Data-Driven, Subscription-Led Demand
FMI indicates that growth is being powered by three structural shifts:
1) Healthy aging becomes category expansion (not just maintenance).
Aging population health management is widening demand into cognitive health, joint support, gut microbiome, and cardiovascular wellness, pulling more specialized SKUs into the mainstream.
2) Personalization upgrades pricing power—and rewrites distribution economics.
Personalized nutrition platforms using biomarker testing and digital health data are creating subscription-based regimens that can command 2–3x pricing premiums over mass-market equivalents while reducing dependency on traditional retail intermediaries.
3) GLP-1 weight management creates a 'nutrient-gap' adjacency wave.
GLP-1 receptor agonist adoption is generating new supplement demand for protein, fiber, and micronutrient products aimed at addressing nutritional gaps linked to reduce caloric intake. FMI's strategic takeaways point to 30+ million North Americans expected to use weight management medications by 2030, underscoring the scale of this adjacent opportunity.
Executive Signal for Buyers: Margin Risk Is Shifting Upstream
FMI highlights raw material costs for vitamins, minerals, and specialty bioactives as the primary margin variables. Supply chain concentration—particularly Chinese API manufacturing for vitamins C, D, and B-complex—continues to create procurement volatility for North American brand owners and contract manufacturers. For decision makers, this is increasingly a specification and sourcing issue, not just a pricing negotiation.
Competitive Momentum: Personalization Platforms Move from Strategy to Operating System
As Stephan Gratziani, CEO of Herbalife, stated regarding the company's strategic direction, "The objective is to enter new segments with personalized offerings while also strengthening relationships with current customers." In February 2026, Herbalife announced the phased rollout of Pro2col, a digital health and wellness operating system designed to provide personalized nutritional supplement recommendations, with U.S. accessibility confirmed by end of H1 2026.
For category leaders and fast-growing challengers alike, this signals a measurable shift: digital engagement + personalization = retention engine, not just marketing.
What the Market Covers
The North American dietary supplements market includes vitamins, minerals, amino acids, proteins, probiotics, and botanical blends sold across multiple delivery forms (tablets, capsules, softgels, powders, gummies) via retail, e-commerce, and practitioner channels across the USA, Canada, and Mexico.
Regulatory framing referenced in the market definition includes:
Segment Signals That Matter Most to Commercial Leaders
Type: Vitamins Lead Value (27.2% in 2026)
Vitamins are projected to hold 27.2% of market value in 2026, supported by continued demand for vitamin D, C, and B-complex across preventive wellness and immune support. Product innovation (bioavailability and combination formulas) and stronger integration into preventive regimens continue reinforcing this base.
Form: Tablets Lead Today; Gummies Accelerate Fastest
Tablets represent 25.3% of form demand in 2026, favored for stability, cost-effectiveness, and scalable manufacturing. At the same time, gummies are the fastest-growing delivery format, driven by consumer preference for palatability and convenience—creating a dual-speed portfolio reality for brands and CDMOs.
Distribution: Store-Based Still Anchors Volume (59.4%), While Non-Store Grows Faster
Store-based distribution is expected to hold 59.4% share in 2026, anchored by pharmacy chains (CVS, Walgreens, Shoppers Drug Mart) and mass retailers (Walmart, Costco). Non-store growth is accelerating via Amazon, DTC brands, and telehealth-linked platforms, particularly where personalization and subscription models reduce reliance on shelf placement.
Regional Growth Outlook: Canada Leads CAGR; USA Leads Absolute Demand
FMI's country view highlights different growth roles across North America:
FMI Analyst View: Retail Margins Compress as Subscriptions Rise
Nandini Roy Choudhury, Principal Consultant for the Food & Beverage Industry at Future Market Insights, notes that personalized nutrition platforms are compressing traditional retail distribution margins by converting consumers to subscription models that bypass pharmacy and mass retail intermediaries. The analyst also points to consolidation dynamics—including the Kimberly-Clark acquisition of Kenvue—and flags Health Canada's NHP regulatory modernization as a source of compliance cost uncertainty for smaller brands operating across the U.S.–Canada border.
Strategic Implications for Buyers and Operators
For executives, procurement heads, and product leaders, FMI's executive takeaways translate into three near-term actions:
Key Players in North American Dietary Supplements Market: USANA Health Sciences, NOW Foods, Optimum Nutrition, Amway, Abbott Laboratories, Bayer AG, Nature's Way, Pfizer Inc., New Chapter, Jamieson Wellness, Metagenics, The Nature's Bounty Co., Herbalife, Garden of Life, GNC Holdings
Methodology
Buy Full Report: https://www.futuremarketinsights.com/checkout/244
Related Reports:
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals.
An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities.
For Press & Corporate Inquiries
Rahul Singh
AVP - Marketing and Growth Strategy
Future Market Insights, Inc.
+91 8600020075
For Sales - sales@futuremarketinsights.com
For Media - Rahul.singh@futuremarketinsights.com
For web - https://www.futuremarketinsights.com/
Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/north-american-dietary-supplements-market-poised-to-add-usd-90-4b-by-2036---future-market-insights-fmi-302705366.html
Deutsche Synchronsprecherinnen und -sprecher erhöhen den Druck auf Streaminganbieter wie Netflix. Hintergrund sind neue Vertragsklauseln, die es erlauben sollen, bereits aufgezeichnete Stimmen für das Training von Systemen mit Künstlicher Intelligenz (KI) zu nutzen. Nach Angaben des Verbands Deutscher Sprecher:innen (VDS) lehnen viele Künstler diese Regelungen ab und verweigern ihre Unterschrift – mit der Folge, dass erste Synchronproduktionen ins Stocken geraten.
Im Zentrum der Kritik steht die Verknüpfung von Engagement und Zustimmung zur KI-Nutzung. „Ich bin nicht bereit, das Training einer Künstlichen Intelligenz zu unterstützen“, sagte Natascha Geisler, deutsche Stimme von Jennifer Lopez, der Deutschen Presse-Agentur. Sie habe eine aktuelle Synchronarbeit für Lopez wegen der Netflix-Vertragsbedingungen abgesagt. Bei den neuen Verträgen gebe es nach ihrer Darstellung keine Möglichkeit, der Nutzung der eigenen Stimme für KI-Training zu widersprechen; die Zustimmung sei Voraussetzung für einen Auftrag.
Zusätzlichen Zündstoff liefert die Frage der Vergütung. Geisler moniert, in den Netflix-Verträgen sei „an keiner Stelle schriftlich festgehalten, dass für das KI-Training eine gesonderte Vergütung vorgesehen ist“. Beim Training würden sämtliche Facetten von Schauspiel und Intonation erfasst, damit KI-Systeme lernen können, unterschiedliche Emotionen zu imitieren. Sie wolle weder „Datenfutter“ sein noch dazu beitragen, dass ihr Berufsstand perspektivisch ersetzt werden könne, sagte die Sprecherin.
Der VDS, der ein Treffen in München mit prominenten deutschen Stimmen unter anderem von Tom Cruise, Renée Zellweger, Cameron Diaz und SpongeBob mitorganisiert hat, drängt auf klare gesetzliche Regeln für den Einsatz von KI in der Branche. Nur eine Regulierung könne aus Sicht des Verbands eine unkontrollierte und illegale Nutzung von Stimmen verhindern und die Qualität menschengemachter Kunstwerke sichern. Netflix verweist unterdessen laut einer Unternehmenssprecherin darauf, dass der Einsatz von KI im Einklang mit geltendem Recht erfolge und beruft sich auf Vereinbarungen, die der Konzern im vergangenen Sommer gemeinsam mit dem Bundesverband Schauspiel getroffen habe.
